Mode
Text Size
Log in / Sign up

Genetic cause identified in fewer than half of congenital heart disease casesGenetic causes identified in fewer than half of heart cases

AI-generated summary of the cited source, checked by automated accuracy review. How we work

Key Takeaway
Consider that genetic testing identifies a cause in fewer than half of CHD cases; interpret negative results cautiously.

This narrative review addresses the genetic underpinnings of congenital heart diseases (CHD), the most common birth defects. The authors synthesize current knowledge on how genetic variants disrupt heart development, offering a framework that links molecular findings to developmental biology. They emphasize that despite advances, a definitive or candidate genetic cause is identified in fewer than half of cases, highlighting the complexity and heterogeneity of CHD genetics.

The review is intended to help clinicians situate molecular findings within the biology of heart formation, sharpen genotype–phenotype interpretation, and support more precise diagnostic and prognostic reasoning. It also touches on emerging regenerative strategies, though these are discussed in a conceptual rather than clinical context.

As a narrative review, it does not present pooled data or systematic methodology. The authors do not report specific trial data, and the review does not provide evidence of treatment efficacy. Limitations are not explicitly stated in the source, but the lack of quantitative synthesis and reliance on selected literature are inherent constraints.

For clinicians, the review offers a conceptual map for integrating genetic testing into CHD care, but it should not be used as a basis for specific treatment decisions. The finding that most cases remain genetically unexplained underscores the need for cautious interpretation of negative genetic results.

Living with a congenital heart condition means dealing with a complex medical journey. For families and doctors, understanding exactly why a heart defect occurred is a major piece of the puzzle for planning future care and treatment.

A review of current research shows that finding a specific genetic cause is harder than many might expect. In fact, a definitive or candidate genetic cause is identified in fewer than half of all cases. This means that even with modern tools, many patients still do not have a clear genetic answer for their condition.

While this data does not offer new treatments, it helps doctors better understand how heart tissue forms during development. By mapping these molecular findings to the biology of heart growth, medical teams can work toward more precise ways to diagnose and predict how a condition might progress over time.

What this means for you:
Less than half of congenital heart disease cases have a clearly identified genetic cause.

Common questions

What is the likelihood of finding a genetic cause for heart issues?

Current research indicates that a definitive or candidate genetic cause is identified in fewer than half of cases. This means that more than 50% of people with congenital heart diseases do not have a known genetic cause identified yet.

How does this information help doctors treat patients?

This information helps clinicians understand the biology of how hearts form. By understanding these molecular details, doctors can improve their ability to interpret symptoms and provide more precise diagnostic reasoning for their patients.

Study Details

Study typeSystematic review
EvidenceLevel 1
PublishedJul 2026
View Original Abstract ↓
Congenital heart diseases (CHDs) encompass a broad spectrum of structural anomalies with substantial clinical and genetic heterogeneity. They are the most common birth defects in humans, and a leading cause of paediatric morbidity and mortality. Yet, its genetic substrate remains difficult to interpret at the bedside: despite advances in cytogenetics and next-generation sequencing, a definitive or candidate genetic cause is identified in fewer than half of cases, and even when a variant is recovered, mapping it onto the developmental program that produces a specific malformation is rarely straightforward for the practising clinician. This narrative review revisits normal cardiogenesis as a single, coordinated developmental program, integrating embryological events with progenitor populations, transcription factor networks, and signalling pathways. We then highlight how perturbation of these developmental modules may result in syndromic and non-syndromic CHD. By aligning embryological events with their regulatory logic, the review offers a developmental framework intended to help clinicians situate molecular findings within the biology of heart formation, sharpen genotype–phenotype interpretation, support more precise diagnostic and prognostic reasoning, and inform emerging regenerative strategies for the malformed and injured heart.
Free Newsletter

Clinical research that matters. Delivered to your inbox.

Join thousands of clinicians and researchers. No spam, unsubscribe anytime.